BioSpace News Archive

Invectys Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to meet the needs of cancer patients, announced the appointment of Rosemary Williams, CPA, in a dual appointment as Vice-President for Administration and Controller.

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of guidelines by the American College of Obstetricians and Gynecologists (ACOG) that support the use of transcervical radiofrequency ablation as a minimally invasive, uterine preserving option for women suffering from symptomatic uterine fibroids.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8.

The range of products are designed to help veterinarians address common - and sometimes debilitating - injuries in horses

Such early detection or rule-out of Alzheimer’s disease non-invasively and affordably is nonexistent in the clinical market today.

There were no reservations in the Former Auditor’s audit report for the relevant period, being the two most recently completed financial years ended March 31, 2020.

The Company recorded Q1 2021 revenue of $6,880,325.

nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully achieved the primary endpoint for the nanoMesh™ Pathogen Inhibiting Protein (PIP) uptake studies

In the near term, we are diligently working with the Exchange to finalize our shareholder meeting materials and the date of the shareholders’ meeting to consider the Arrangement with Satellos is expected to be announced in the near future.

According to The Insight Partners market research study titled “3D Printed Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Dosage Forms and Technology,” the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019.